The first KSHV protein which can antagonize PML NBs during de novo infection is one of the viral tegument proteins ORF75 which specifically targets ATRX for degradation in a proteasome-independent manner and triggers redistribution of Daxx, without hampering other PML NB constituents (Figure 3; Full et al., 2014). Here, ATRX is linked to infection.